Search

everythinglearnresearchcommunity

for

Search:↓

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Diabetes and necrotizing fasciitis together can be deadly.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

Silymarin and metformin together most improved hormone levels and ovulation in women with PCOS.

Polygonum multiflorum, especially emodin, may help treat hair loss by targeting specific proteins, offering a new approach beyond traditional therapies.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

JAK inhibitors may reduce depression in people with alopecia areata.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Follicular porokeratosis may be linked to diabetes and can lead to hair loss.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

The gels improved wound healing in diabetic mice but need human trials.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Interest in JAK inhibitors for hair loss increased significantly after media coverage and FDA approval.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Finasteride may help treat recurrent priapism in sickle cell anemia.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Applying certain vesicles from umbilical cord stem cells helps heal skin wounds in diabetic mice by reducing cell death and inflammation.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Vitamin D is needed for metformin to lower prolactin effectively.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.